SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-012533
Filing Date
2024-04-01
Accepted
2024-04-01 17:29:05
Documents
84
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 3112578
2 ex4-1.htm EX-4.1 93948
3 ex10-58.htm EX-10.58 16330
4 ex23-1.htm EX-23.1 3432
5 ex31-1.htm EX-31.1 18216
6 ex31-2.htm EX-31.2 17722
7 ex32-1.htm EX-32.1 7548
8 ex32-2.htm EX-32.2 6554
9 ex97-1.htm EX-97.1 43975
10 form10-k_001.jpg GRAPHIC 82048
11 form10-k_002.jpg GRAPHIC 52983
12 form10-k_003.jpg GRAPHIC 21310
13 form10-k_004.jpg GRAPHIC 45353
14 form10-k_005.jpg GRAPHIC 24516
15 form10-k_006.jpg GRAPHIC 23180
16 form10-k_007.jpg GRAPHIC 30789
17 form10-k_008.jpg GRAPHIC 11515
18 form10-k_009.jpg GRAPHIC 19951
19 form10-k_010.jpg GRAPHIC 13099
  Complete submission text file 0001493152-24-012533.txt   11617117

Data Files

Seq Description Document Type Size
20 XBRL SCHEMA FILE mymd-20231231.xsd EX-101.SCH 61446
21 XBRL CALCULATION FILE mymd-20231231_cal.xml EX-101.CAL 58680
22 XBRL DEFINITION FILE mymd-20231231_def.xml EX-101.DEF 310121
23 XBRL LABEL FILE mymd-20231231_lab.xml EX-101.LAB 558429
24 XBRL PRESENTATION FILE mymd-20231231_pre.xml EX-101.PRE 425225
88 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1543861
Mailing Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36268 | Film No.: 24811214
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)